Business Description
LianBio
NAICS : 325412
SIC : 2834
ISIN : US53000N1081
Share Class Description:
LIANY: ADRDescription
LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializing medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets. It is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 88.72 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | -28.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.26 | |||||
| 9-Day RSI | 10.74 | |||||
| 14-Day RSI | 10.61 | |||||
| 6-1 Month Momentum % | -89.73 | |||||
| 12-1 Month Momentum % | -85.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.06 | |||||
| Quick Ratio | 10.06 | |||||
| Cash Ratio | 9.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 4.29 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -36.74 | |||||
| ROA % | -29.02 | |||||
| ROIC % | -589.49 | |||||
| ROC (Joel Greenblatt) % | -1683.4 | |||||
| ROCE % | -38.13 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.16 | |||||
| Price-to-Tangible-Book | 0.16 | |||||
| EV-to-EBIT | 2.06 | |||||
| EV-to-EBITDA | 2.08 | |||||
| EV-to-FCF | 2.6 | |||||
| Price-to-Net-Current-Asset-Value | 0.16 | |||||
| Price-to-Net-Cash | 0.17 | |||||
| Earnings Yield (Greenblatt) % | 48.54 | |||||
| FCF Yield % | -260.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LIANY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LianBio Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.81 | ||
| Beta | 0 | ||
| Volatility % | 176.14 | ||
| 14-Day RSI | 10.61 | ||
| 14-Day ATR ($) | 0.075385 | ||
| 20-Day SMA ($) | 0.301988 | ||
| 12-1 Month Momentum % | -85.01 | ||
| 52-Week Range ($) | 0.241 - 4.99 | ||
| Shares Outstanding (Mil) | 108.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LianBio Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LianBio Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
LianBio Frequently Asked Questions
What is LianBio(LIANY)'s stock price today?
The current price of LIANY is $0.30. The 52 week high of LIANY is $4.99 and 52 week low is $0.24.
When is next earnings date of LianBio(LIANY)?
The next earnings date of LianBio(LIANY) is 2024-05-10 Est..
Does LianBio(LIANY) pay dividends? If so, how much?
LianBio(LIANY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers